Myristoylated form of Pep2m; Cell-permeable inhibitor of the interaction between AMPA receptor and N-ethylmaleimide-sensitive fusion protein (NSF).
CAT# | R1029 |
Synonyms/Alias | myr-pep2m |
M.F/Formula | C63H118N18O14S |
M.W/Mr. | 1383.8 |
Sequence | Myr-KRMKVAKNAQ |
Labeling Target | AMPA receptor |
Appearance | White lyophilised solid |
Purity | >98% |
Activity | Inhibitor |
* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).
Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!
Zonisamide, sold as brand name Zonegran, is a derivative of 3-(sulfamoylmethyl)-l,2-benzisoxazole. It is a membe ...
NoxA1ds is derived from a peptide whose structure is based on a short sequence of an essential Nox subunit. It b ...
Deslorelin acetate, marketed under the trade names Ovuplant, SucroMate and Suprelorin, is an injectable gonadotr ...
Norleual is a potent inhibitor of the HGF/Met system, which inhibited the prosurvival effects of HGF and suppres ...
st-Ht31, a protein kinase A (PKA)-anchoring inhibitor, greatly induces robust cholesterol or phospholipid effl ...